What's news?

News

• 2013-04-26
  Release of 2012 Reference Document (French only)
• 2013-04-24
  Q1 2013 revenues
• 2013-04-23
  Liquidity agreement (French only)
• 2013-03-18
  Adocia announces its phase III development program for the treatment of diabetic foot ulcer. This program has been validated by scientific advice from the European Medicines Agency
• 2013-02-19
  ADOCIA reports a revenue multiplied by 2.5 with a strong cash position for 2012
• 2013-02-06
  Bio CEO & Investor Conference - 11-12 February 2013 - The Waldorf Astoria, New York, USA
• 2013-01-07
  Adocia announces its financial calendar for 2013 as well as its participation to upcoming investor conferences
• 2012-10-30
  Adocia announces the strong growth of its turnover
• 2012-10-22
  Adocia is extending its intellectual property to new formulations of monoclonal antibodies
• 2012-10-01
  EASD 2012 - 48th Annual Meeting of the European Association for the Study of Diabetes - 1-5 October 2012, Messe Süd, Berlin, Germany
• 2012-09-12
  Bio India International Conference - 12-13 September 2012, Grand Hyatt, Mumbai, India
• 2012-09-07
  DFSICON 2012 - 11th Annual Meeting of Diabetic Foot Society of India - 7-9 September 2012, Hyderabad, India
• 2012-09-03
  Financial results and business report for the first half of 2012
• 2012-09-02
  WUWHS 2012 - 4th Congress of the World Union of Wound Healing Societies - 2-6 September 2012, Yokohama, Japon
• 2012-06-13
  Adocia announces a strengthened intellectual property on its lead project for its chronic wounds treatment
• 2012-05-30
  Additional contribution to Liquidity Agreement with Dexia Securities France (French only)
• 2012-04-26
  ADOCIA maintains its dynamic growth: revenue of 1st quarter 2012
• 2012-04-23
  ADOCIA reports positive phase II clinical results
• 2012-04-02
  2011 annual financial results - 2011: a key milestone in ADOCIA's development
• 2012-03-15
  ADOCIA increases the size of its Initial Public Offering to E27.4 million through the partial...
• 2012-03-15
  Liquidity agreement with Dexia Securities France (French only)
• 2012-02-29
  ADOCIA reports strong growth in operating income in 2011
• 2012-02-28
  ADOCIA reports positive phase IIa clinical results on its fast-acting human insulin, HinsBet®
• 2012-02-14
  ADOCIA carries out, with much success, the first IPO of the year...
• 2012-01-26
  ADOCIA launches its IPO on the NYSE Euronext regulated market in Paris
• 2012-01-18
  ADOCIA announces the registration of its Document de base (French only)
• 2011-06-24
  ADOCIA launches Phase IIa clinical study on type 1 diabetic patients with its fast-acting human insulin, HinsBet®
• 2011-06-15
  ADOCIA announces the communication of its clinical results at three major conferences
• 2011-03-15
  ADOCIA reports positive phase I clinical results on HinsBet®, a fast-acting human insulin
• 2010-01-05
  Adocia announces today the closing of its second financing round of 14 M€.
• 2008-01-21
  ADOCIA has raised 12 M€ in order to finance its development of innovative pharmaceutical products...